NO942303D0 - Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav - Google Patents
Farmasöytisk preparat, samt fremgangsmåte for fremstilling deravInfo
- Publication number
- NO942303D0 NO942303D0 NO942303A NO942303A NO942303D0 NO 942303 D0 NO942303 D0 NO 942303D0 NO 942303 A NO942303 A NO 942303A NO 942303 A NO942303 A NO 942303A NO 942303 D0 NO942303 D0 NO 942303D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU914060A HUT63579A (en) | 1991-12-20 | 1991-12-20 | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
PCT/HU1992/000060 WO1993012775A1 (en) | 1991-12-20 | 1992-12-18 | Pharmaceutical composition and process for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942303D0 true NO942303D0 (no) | 1994-06-17 |
NO942303L NO942303L (xx) | 1994-08-17 |
Family
ID=10966728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942303A NO942303D0 (no) | 1991-12-20 | 1994-06-17 | Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav |
Country Status (27)
Country | Link |
---|---|
US (1) | US5589513A (xx) |
EP (1) | EP0617615A1 (xx) |
JP (1) | JPH07502730A (xx) |
KR (1) | KR940703655A (xx) |
AU (1) | AU677170B2 (xx) |
BG (1) | BG98827A (xx) |
BR (1) | BR9206950A (xx) |
CA (1) | CA2125776A1 (xx) |
CZ (1) | CZ147494A3 (xx) |
EC (1) | ECSP930933A (xx) |
EE (1) | EE03015B1 (xx) |
FI (1) | FI942932A (xx) |
HU (2) | HUT63579A (xx) |
IL (1) | IL104150A (xx) |
LT (1) | LT3119B (xx) |
LV (1) | LV10386B (xx) |
MY (1) | MY111055A (xx) |
NO (1) | NO942303D0 (xx) |
NZ (1) | NZ246384A (xx) |
PH (1) | PH31073A (xx) |
PL (1) | PL172048B1 (xx) |
RO (1) | RO115785B1 (xx) |
RU (1) | RU2125448C1 (xx) |
SI (1) | SI9200404A (xx) |
SK (1) | SK74494A3 (xx) |
WO (1) | WO1993012775A1 (xx) |
ZA (1) | ZA929883B (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5844003A (en) * | 1991-04-04 | 1998-12-01 | Innovations Foundation | Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
US5817336A (en) * | 1993-04-02 | 1998-10-06 | Orion-Yhtyma Oy | Composition containing selegiline |
DE4432610C1 (de) * | 1994-09-13 | 1996-02-01 | Knoll Ag | Verfahren zur Herstellung von Selegilin-Hydrochlorid |
AU723047B2 (en) | 1995-02-10 | 2000-08-17 | University Of Toronto Innovations Foundation, The | Deprenyl compounds for treatment of glaucoma |
JP4499208B2 (ja) * | 1998-10-29 | 2010-07-07 | 株式会社フジモト・コーポレーション | 新規な光学活性アミノペンタン誘導体 |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
HUP9902482A2 (hu) * | 1999-07-22 | 2002-04-29 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására |
EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
DE102009045056A1 (de) * | 2009-09-28 | 2011-03-31 | Henkel Ag & Co. Kgaa | Fleckenvorbehandlungsmittel |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
CA3078723A1 (en) | 2016-11-28 | 2018-05-31 | Nachiappan Chidambaram | Oral testosterone undecanoate therapy |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1227447B (de) * | 1962-03-30 | 1966-10-27 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Phenylisopropylaminen |
HU193662B (en) * | 1983-12-20 | 1987-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing synergetic pharmaceutical composition of antidepressive aktivity |
HU207282B (en) * | 1984-05-31 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them |
EP0241809B1 (de) * | 1986-04-16 | 1990-08-08 | ASTA Pharma Aktiengesellschaft | Synergistische Kombination von Amantadin und Selegilin |
HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
HU197510B (en) * | 1986-12-19 | 1989-04-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick |
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
HU208484B (en) * | 1988-08-17 | 1993-11-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia |
CA2037178A1 (en) * | 1990-02-28 | 1991-08-29 | Albert Walter Brzeczko | Deprenyl/l-dopa/carbidopa pharmaceutical composition |
GB9011767D0 (en) * | 1990-05-25 | 1990-07-18 | Britannia Pharmaceuticals Ltd | Pharmaceutical compositions |
US5169868A (en) * | 1991-03-01 | 1992-12-08 | University Of Saskatchewan | Aliphatic propargylamines as specific mao-b inhibitors |
US5444095A (en) * | 1991-04-04 | 1995-08-22 | University Of Toronto, Innovations Foundation | Use of deprenyl to rescue damaged nerve cells |
HU209605B (en) * | 1991-04-15 | 1994-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of wather-free transdermal preparation |
US5326770A (en) * | 1992-07-17 | 1994-07-05 | The Du Pont Merck Pharmaceutical Company | Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals |
-
1991
- 1991-12-20 HU HU914060A patent/HUT63579A/hu unknown
-
1992
- 1992-12-18 US US08/256,128 patent/US5589513A/en not_active Expired - Fee Related
- 1992-12-18 RU RU94031161A patent/RU2125448C1/ru active
- 1992-12-18 PH PH45474A patent/PH31073A/en unknown
- 1992-12-18 MY MYPI92002341A patent/MY111055A/en unknown
- 1992-12-18 SI SI9200404A patent/SI9200404A/sl unknown
- 1992-12-18 WO PCT/HU1992/000060 patent/WO1993012775A1/en not_active Application Discontinuation
- 1992-12-18 CZ CZ941474A patent/CZ147494A3/cs unknown
- 1992-12-18 BR BR9206950A patent/BR9206950A/pt not_active Application Discontinuation
- 1992-12-18 NZ NZ246384A patent/NZ246384A/en unknown
- 1992-12-18 PL PL92304116A patent/PL172048B1/pl unknown
- 1992-12-18 EP EP93901880A patent/EP0617615A1/en not_active Withdrawn
- 1992-12-18 AU AU32652/93A patent/AU677170B2/en not_active Ceased
- 1992-12-18 SK SK744-94A patent/SK74494A3/sk unknown
- 1992-12-18 ZA ZA929883A patent/ZA929883B/xx unknown
- 1992-12-18 CA CA002125776A patent/CA2125776A1/en not_active Abandoned
- 1992-12-18 RO RO94-01015A patent/RO115785B1/ro unknown
- 1992-12-18 IL IL104150A patent/IL104150A/xx not_active IP Right Cessation
- 1992-12-18 KR KR1019940702143A patent/KR940703655A/ko active IP Right Grant
- 1992-12-18 JP JP5510411A patent/JPH07502730A/ja active Pending
- 1992-12-20 LV LVP-92-547A patent/LV10386B/en unknown
- 1992-12-21 LT LTIP249A patent/LT3119B/lt not_active IP Right Cessation
-
1993
- 1993-05-25 EC EC1993000933A patent/ECSP930933A/es unknown
-
1994
- 1994-06-02 BG BG98827A patent/BG98827A/xx unknown
- 1994-06-17 NO NO942303A patent/NO942303D0/no unknown
- 1994-06-17 FI FI942932A patent/FI942932A/fi unknown
- 1994-08-10 EE EE9400117A patent/EE03015B1/xx unknown
-
1995
- 1995-06-16 HU HU95P/P00218P patent/HU211478A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
LV10386A (lv) | 1995-02-20 |
AU677170B2 (en) | 1997-04-17 |
ECSP930933A (es) | 1994-04-20 |
EE03015B1 (et) | 1997-08-15 |
MY111055A (en) | 1999-08-30 |
PL172048B1 (pl) | 1997-07-31 |
NO942303L (xx) | 1994-08-17 |
HU211478A9 (en) | 1995-11-28 |
KR940703655A (ko) | 1994-12-12 |
SK74494A3 (en) | 1995-01-12 |
WO1993012775A1 (en) | 1993-07-08 |
ZA929883B (en) | 1994-05-16 |
FI942932A0 (fi) | 1994-06-17 |
PH31073A (en) | 1998-02-05 |
IL104150A (en) | 1997-11-20 |
RO115785B1 (ro) | 2000-06-30 |
LTIP249A (en) | 1994-07-15 |
RU2125448C1 (ru) | 1999-01-27 |
CZ147494A3 (en) | 1995-01-18 |
JPH07502730A (ja) | 1995-03-23 |
BG98827A (en) | 1995-06-30 |
FI942932A (fi) | 1994-06-17 |
LT3119B (en) | 1994-12-27 |
CA2125776A1 (en) | 1993-07-08 |
AU3265293A (en) | 1993-07-28 |
SI9200404A (en) | 1993-06-30 |
LV10386B (en) | 1995-12-20 |
HUT63579A (en) | 1993-09-28 |
BR9206950A (pt) | 1995-11-28 |
NZ246384A (en) | 1996-02-27 |
HU914060D0 (en) | 1992-03-30 |
US5589513A (en) | 1996-12-31 |
EP0617615A1 (en) | 1994-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO921958L (no) | Farmasoeytisk preparat | |
NO922006L (no) | Farmasoeytisk preparat | |
NO941719L (no) | Farmasöytisk preparat med regulert frigjöringsvirkning | |
NO924768D0 (no) | Farmasoeytisk preparat og fremgangsmaate for dets fremstilling | |
NO962694D0 (no) | Percutant farmasöytisk preparat | |
FI941137A (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
NO944700D0 (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
NO2009028I1 (no) | Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat | |
BG97198A (bg) | Диалкокси-пиридинил-бензимидазолови производни, метод за получаването им и тяхното фармацевтично приложение | |
EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
NO942303D0 (no) | Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav | |
DK0562583T3 (da) | Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
DK0840548T3 (da) | Synergistisk, herbicid sammensætning samt fremgangsmåde til fremstilling deraf | |
FI941914A (fi) | 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö | |
FI955123A (fi) | Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi | |
KR900009580A (ko) | 벤젠 유도체, 그 제조방법 및 그를 함유하는 약학 조성물 | |
FI893721A0 (fi) | Synergistisk soetningskomposition och preparat innehaollande densamma. | |
NO305750B1 (no) | Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene | |
NO913162D0 (no) | Farmasoeytisk preparat for behandling av tonsillitt. | |
BR9200004A (pt) | Composto,metodo para sua preparacao,e formulacao farmaceutica | |
EE9400182A (et) | Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu | |
FI941800A0 (fi) | Psoriasiksen vastaiset lääkeainekoostumukset ja menetelmä niiden valmistamiseksi | |
FI961717A0 (fi) | Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi | |
NO911298L (no) | Farmasoeytisk preparat og anvendelse derav. |